Cytek Biosciences, Inc. (CTKB) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

ProductService
012M25M38M50M62M75M88M100MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Revenue by Geography

UNITED STATESEMEAAsia PacificOther
025M50M75M100M125M150M175M200MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
025M50M75M100M125M150M175M200MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Margin (%)

Gross MarginOperating MarginNet Income Margin
012253850627588100Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Operating Expenses

Research And Development ExpensesSelling And Marketing ExpensesGeneral And Administrative Expenses
06M12M19M25M31M38M44M50MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

EBITDA

EBITDA
-20M-16M-13M-9M-6M-2M2M5M9MQ4 2024Q1 2025Q2 2025Q3 2025

EPS

EPSEPS Diluted
000001111Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Revenue Variation (%)

Revenue Variation
-40-32-25-18-10-251220Q4 2024Q1 2025Q2 2025Q3 2025

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
02505007501K1K2K2K2KQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Revenue YoY Variation (%)

Revenue YoY Variation
-9-8-6-5-4-2-112Q4 2024Q1 2025Q2 2025Q3 2025

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
0255075100125150175200Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Price-to-Earning Ratio

P/E Ratio
-30-22-15-808152230Q4 2024Q1 2025Q2 2025

Income Breakdown

Rule Of 40 (EBITDA)Rule Of 40 (FCF)
02581012151820Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Per Share Metrics

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
04M8M11M15M19M22M26M30MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
000001111Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
💰 Cash Flow Statement

Operating Cash Flow

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
000001111Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Free Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
0500K1M2M2M2M3M4M4MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Cash Flow to Debt Ratio

Cash At End Of Period
025M50M75M100M125M150M175M200MQ4 2024Q1 2025Q2 2025Q3 2025
🏦 Balance Sheet
📈 Key Metrics